Glen S. Woods
Glen S. Woods
Stop FollowingGlen S. Woods
View as an RSS Feed
- Could Enzo Biochem's Intellectual Property Lawsuits Be Worth Billions?
- Big Profits In Intellectual Property, But Beware Of Risks
- Specialty Pharmacies: An Overlooked Segment In A Profitable Industry
- Dunkin' Donuts Takes On The Egg McMuffin
- 3 Radiotherapy Companies That Could Make Big Gains In 2013
- Retail Pharmacy Stocks Continue To Rise Despite Stiff Competition
- Retail Pharmacy Stocks, A Good Investment As Affordable Care Act Nears
- McDonald's And Darden Court Customers With New Menu Items And New Concepts
- Cargill Makes A Big Investment In The Future Of Stevia
- Diagnosis And Treatment Of Disease With Radiotherapies May Prove Profitable In 2013
- Biopharmaceutical Companies Developing Insulin Pills May Bring High Profits
-
Adding Doughnuts To Your Portfolio May Increase Your Profits
- Celgene's Stock Runs On A Strong Pipeline Of Drugs And Projected Sales
- SodaStream Looks To Have Big Growth Potential In 2013
- Companies Gear Up As Health Canada Approves Stevia As Additive For Food And Beverage Use
- Distinguishing Fad From Trend In Gluten Free And Stevia Markets May Expose Profitable Investment Opportunities
- Galena Biopharma: Catalysts Have Led Its Stock Higher
- Developing Synergistic Relationship Between Sugar Manufacturers And Stevia Could Prove To Have High Investment Potential
-
Investments In The Fight Against Cancer: The Analysts' Choices
- Isotope Manufacturing Companies Step Up As Aging Nuclear Reactors And Government Policies Threaten Nuclear Medicine
-
Feed the Masses, Live With The Classes: How McDonald's Has Weathered The Recession
- Starbucks Adding Stevia To Their Energy Drinks May Be A Boost For Stevia Growers
- Is Baxter A Bargain? Management Seems To Think So
